Company Search:
Advanced Search
Sponsored Links
Biofrontera AG Company Snapshot
Biofrontera AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other companies in this sector in Germany: MediGene AG (2015 sales of 6.81 million Euro [US$7.35 million] of which 63% was OUTLINCENCEDPRODUCTS), 4Sc AG (3.27 million Euro [US$3.53 million] of which 70% was Drug Discovery & Development), and Wilex Ag (2.28 million Euro [US$2.47 million] ).

Sales Analysis. Biofrontera AG reported sales of 4.14 million Euro (US$4.47 million) for the year ending December of 2015. This represents an increase of 33.7% versus 2014, when the company's sales were 3.10 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biofrontera AG
  Stock Performance Chart for Biofrontera AG
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 3.99
(Figures in Euro)
1 Week -8.6%   13 Weeks -11.1%  
4 Weeks 24.7%   52 Weeks 79.3%  
Biofrontera AG Key Data:
  Ticker: B8F Country: Germany
  Exchanges: FRA LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 4,137,917
(Year Ending Jan 2016).
Employees: 58
  Currency: Euro Market Cap: 121,118,122
  Fiscal Yr Ends: December Shares Outstanding: 30,347,813
  Share Type: Stammaktie Closely Held Shares: 13,268,873
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.